Igm Antibody Laboratories manufactures the cov igg/igm rapid test reagents distributed by Genprice. The Cov Igg/Igm Rapid Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Cov products are available in stock. Specificity: Cov Category: Igg/Igm Group: Rapid Test
Panbio™ COVID-19 IgG/IgM Rapid Test |
Abbott |
25 Tests/Kit |
EUR 264 |
Human Echovirus (ECHO) IgM Rapid Test Kit |
Abbexa |
20 tests |
EUR 326.4 |
|
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
All test |
25 tests |
EUR 292.8 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Chikungunya IgG/IgM Test Card |
Innovation Biotech |
4.0mm (strip in a card) 25cards/box |
EUR 0.7 |
Human Toxoplasma (TOX) IgG Rapid Test Kit |
Abbexa |
20 tests |
EUR 260.4 |
|
Rapid Test information
SARS-CoV-2 Antigen Rapid Test Kit |
CoV2Ag-25 |
UnScience |
25T/kit |
EUR 42 |
|
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
Human Coxsackievirus group B (CVB) IgM Rapid Test Kit |
abx092083-20tests |
Abbexa |
20 tests |
EUR 309.6 |
|
Human Coxsackievirus A16 (CV-A16) IgM Rapid Test Kit |
abx092087-20tests |
Abbexa |
20 tests |
EUR 393.6 |
|
Human Respiratory Syncytial Virus (RSV) IgM Rapid Test Kit |
abx092086-20tests |
Abbexa |
20 tests |
EUR 309.6 |
|
Human Rubella Virus (RV) IgG Rapid Test Kit |
abx092097-20tests |
Abbexa |
20 tests |
EUR 260.4 |
|
Human Rabies Virus (HRV) IgG Rapid Test Kit |
abx092100-20tests |
Abbexa |
20 tests |
EUR 410.4 |
|
Human Hepatitis A Virus IgG Rapid Test Kit |
abx092012-25tests |
Abbexa |
25 tests |
EUR 510 |
|
Human Helicobacter Pylori (HP) IgG Rapid Test Kit |
abx092090-20tests |
Abbexa |
20 tests |
EUR 276 |
|
Human Chlamydia Pneumoniae (CP) IgG Rapid Test Kit |
abx092079-20tests |
Abbexa |
20 tests |
EUR 309.6 |
|
SARS-CoV-2 Rapid Antigen Test Nasal |
9901-NCOV-03G |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
Human Mycoplasma Pneumoniae (MP) IgG Rapid Test Kit |
abx092081-20tests |
Abbexa |
20 tests |
EUR 309.6 |
|